Site Search
As a highly committed National Corporate Champion — Daugherty employees have been involved for nearly 15 years and have raised more than $275,000 to help advance the Foundation’s mission. Their steadfast support continues to fuel some of the most innovative CF research in the world.
CF Foundation national and local events, provide your company with opportunities to align with a results-driven organization and better position your brand.
A new law that allows patients with rare diseases to participate in clinical trials without losing eligibility for public health care benefits went into effect yesterday. The bill, known as the “Improving Access to Clinical Trials Act” (IACT), was championed by the Cystic Fibrosis Foundation and signed into law in October 2010.
The Cystic Fibrosis Foundation's successful business model was at the center of a congressional briefing in Washington, D.C., today, which focused on strategies for jump-starting drug development for rare diseases.